Uncategorized
Ocular Therapeutix reports $11.4 million net loss in second quarter
Ocular Therapeutix reported a net loss of approximately $11.4 million, or $0.46 per share, in the second quarter of 2016 compared with a net loss of $10 million, or $0.45 per share, in the same quarter last year, according to a company press release.Sales of ReSure Sealant generated about $441,000 in revenue, an increase of $107,000 over the same period last year.